Evotec SE Revenue vs. Current Valuation

EVO Stock  USD 5.02  0.08  1.57%   
Based on the measurements of profitability obtained from Evotec SE's financial statements, Evotec SE ADR may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in May. Profitability indicators assess Evotec SE's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2003-12-31
Previous Quarter
170.3 M
Current Value
196.3 M
Quarterly Volatility
63.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of the 28th of April 2024, Price To Sales Ratio is likely to grow to 3.26. Also, Days Sales Outstanding is likely to grow to 114.03. At this time, Evotec SE's Operating Income is very stable compared to the past year. As of the 28th of April 2024, Income Tax Expense is likely to grow to about 21.9 M, while Accumulated Other Comprehensive Income is likely to drop (35.3 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.360.224
Way Up
Slightly volatile
For Evotec SE profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Evotec SE to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Evotec SE ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Evotec SE's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Evotec SE ADR over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.25)
Revenue Per Share
2.2085
Quarterly Revenue Growth
(0.16)
Return On Assets
0.0003
Return On Equity
(0.07)
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Evotec SE ADR Current Valuation vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Evotec SE's current stock value. Our valuation model uses many indicators to compare Evotec SE value to that of its competitors to determine the firm's financial worth.
Evotec SE ADR is rated # 5 in revenue category among related companies. It is rated below average in current valuation category among related companies reporting about  1.11  of Current Valuation per Revenue. At this time, Evotec SE's Total Revenue is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Evotec SE by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evotec SE's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evotec SE's earnings, one of the primary drivers of an investment's value.

Evotec Revenue vs. Competition

Evotec SE ADR is rated # 5 in revenue category among related companies. Market size based on revenue of Health Care industry is currently estimated at about 253.52 Billion. Evotec SE adds roughly 820.8 Million in revenue claiming only tiny portion of equities under Health Care industry.

Evotec Current Valuation vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Evotec SE

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
820.8 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Evotec SE

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
910.3 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Evotec Current Valuation vs Competition

Evotec SE ADR is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about (13.88 Billion). Evotec SE adds roughly 910.3 Million in current valuation claiming only tiny portion of equities under Health Care industry.

Evotec SE Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Evotec SE, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Evotec SE will eventually generate negative long term returns. The profitability progress is the general direction of Evotec SE's change in net profit over the period of time. It can combine multiple indicators of Evotec SE, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-33.7 M-35.3 M
Operating Income1.7 M1.8 M
Net Loss-95 M-90.2 M
Income Tax Expense20.9 M21.9 M
Income Before Tax-74.1 M-70.4 M
Total Other Income Expense Net-80.8 M-76.8 M
Net Interest Income-4.3 M-4.5 M
Interest Income9.6 M10.1 M
Net Loss-158.1 M-150.2 M
Net Income Applicable To Common Shares247.8 M260.2 M
Change To Netincome-142.7 M-135.6 M
Net Loss(0.47)(0.50)
Income Quality(0.40)(0.38)
Net Income Per E B T 0.81  0.68 

Evotec Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Evotec SE. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Evotec SE position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Evotec SE's important profitability drivers and their relationship over time.

Use Evotec SE in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.

Evotec SE Pair Trading

Evotec SE ADR Pair Trading Analysis

The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE ADR to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Evotec SE position

In addition to having Evotec SE in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Care ETFs Thematic Idea Now

Health Care ETFs
Health Care ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:
Check out Investing Opportunities.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Evotec Stock analysis

When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
To fully project Evotec SE's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Evotec SE ADR at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Evotec SE's income statement, its balance sheet, and the statement of cash flows.
Potential Evotec SE investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Evotec SE investors may work on each financial statement separately, they are all related. The changes in Evotec SE's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evotec SE's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.